Last reviewed · How we verify
NCT05306158
Dual Use Approach Bias Training for Nicotine Addiction
NA trial testing CC+ECIG Condition in Tobacco Smoking in 107 participants. Completed in 30 November 2024.
30 September 2024
Quick facts
| Lead sponsor | University of Houston |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 107 |
| Start date | 3 October 2022 |
| Primary completion | 30 September 2024 |
| Estimated completion | 30 November 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- CC+ECIG Condition
- CC Condition
- Sham Condition
Conditions studied
- Tobacco Smoking — all drugs for Tobacco Smoking →
- Electronic Cigarette Use — all drugs for Electronic Cigarette Use →
- Substance Use — all drugs for Substance Use →
Sponsor
University of Houston
Who can join
18 and older, any sex, with Tobacco Smoking or Electronic Cigarette Use. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The present project will evaluate the initial efficacy of approach bias retraining among dual combustible cigarette (CC) and electronic cigarette (ECIG) users. The study employs a randomized controlled design to follow 90 experienced dual CC/ECIG users motivated to quit nicotine as they engage in a self-guided quit attempt following approach bias retraining.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Study protocol for approach bias retraining for nicotine addiction among dual combustible and electronic cigarette users.
Clausen B, Rinck M, Nizio P, Matoska CT, et al · · 2023 · PMID 36905980 · DOI 10.1016/j.cct.2023.107145
Verify or expand the search:
- PubMed search for NCT05306158
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Tobacco Smoking
Currently open trials in the same condition.
- NCT07398443 — Using Novel Behavioral Economic Measures to Characterize Dual Marijuana and Tobacco Use in Young Adults · NA · recruiting
- NCT07132814 — Abuse Liability for Five Modern Oral Nicotine Products · NA · recruiting
- NCT07129590 — Trauma-Informed Care for Smoking Cessation for Pregnancy · NA · recruiting
- NCT07039175 — Intervention to Increase Intention to Change Alcohol/Tobacco Use in Veterans With Chronic Disease · Phase 3 · recruiting
- NCT07236580 — Buteyko Breathing and Approach of Smoking Hygiene: Effects on Dysfucntion of Eustachian Tube and Lung Functions · NA · recruiting
Other University of Houston trials
Trials by the same sponsor.
- NCT07024992 — Enhancing Smoking Cessation for African American People Everywhere · Phase 2 · not yet recruiting
- NCT07025772 — Shaping Habitual Impulses For a Tobacco-free Style · NA · recruiting
- NCT07007195 — Smart Olfaction App to Reduce Relapse · EARLY_PHASE1 · not yet recruiting
- NCT06918821 — Reducing Obesity Through Play Among Toddlers: Tiny Steps to Health (TSHS) Study · NA · recruiting
- NCT07227220 — Summer Youth Employment Programs for Health Promotion · EARLY_PHASE1 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05306158 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Houston
- Last refreshed: 27 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05306158.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing